Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-07-06T21:15:38.511Z Has data issue: false hasContentIssue false

35 - Epidemiology, Diagnosis, Staging and the Medical-Surgical Management of Lung Cancers

from PART III - ORGAN-SPECIFIC CANCERS

Published online by Cambridge University Press:  18 May 2010

Rex Yung
Affiliation:
Assistant Professor of Medicine and Oncology Director of Pulmonary Oncology and Bronchology Sidney Kimmel Comprehensive Cancer, Center Johns Hopkins University School of Medicine Baltimore, MD
Jean-François H. Geschwind
Affiliation:
The Johns Hopkins University School of Medicine
Michael C. Soulen
Affiliation:
University of Pennsylvania School of Medicine
Get access

Summary

Lung cancer (LC) is the leading cause of cancer mortality, and even as the annual incidence of LC may have reached a plateau in the United States, making it the second most prevalent cancer for both men and women. LC mortality continues to exceed the deaths from breast, prostate and colon cancers combined (1). Of note, LC mortality as a single cause of death is even greater than deaths due to cerebral vascular accidents, hence making it the second single cause of death in the United States, after heart diseases. The widespread availability of high-speed multi-slice detector computer-axial tomography (MDCT) scanners, implementation of prospective controlled and uncontrolled LC screening studies (2, 3), unwarranted proprietary “screening” services and incidental findings on scans performed for other thoracoabdominal indications have led to the frequent finding of lung nodules. If experience with other early detection tests such as mammography and prostate-specific antigen is any indication, there will be an expected increase in the diagnosis of “early stage” LCs (1), although whether this would lead to meaningful reduction in disease-specific mortality remains to be seen as there is much debate about the potential efficacy of such screenings (4–6). Parallel with the improvement in diagnostic imaging are advances made in the fields of cancer diagnosis, including real-time image-guided tissue biopsies and molecular characterization of thoracic malignancies.

Type
Chapter
Information
Interventional Oncology
Principles and Practice
, pp. 424 - 439
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Jemal, A, Siegal, R, Ward, E, et al. Cancer statistics, 2007. CA Cancer J Clin, 2007; 57: 43–66.CrossRefGoogle ScholarPubMed
Henschke, C I, Shaham, D, Yankelevitz, D F, et al. CT screening for lung cancer: Past and ongoing studies. Semin Thorac Cardiovasc Surg, 2005; 17: 99–106.CrossRefGoogle ScholarPubMed
National Lung Screening Trial (NLST). National Cancer Institute Web site. http://www.cancer.gov/nlst. Accessed May 21, 2007.
International Early Lung Cancer Action Program Investigators: Henschke, C I, Yankelevitz, D F, Libby, D M, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med, 2006; 355: 1763–1771.Google Scholar
Bach, P B, Jett, J R, Pastorino, U, et al. Computed tomography screening and lung cancer outcomes. JAMA, 2007; 297: 953–961.CrossRefGoogle ScholarPubMed
Welch, H G, Woloshin, S, Schwartz, L M, et al. Overstating the evidence for lung cancer screening: The International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med, 2007; 167: 2289–2295.CrossRefGoogle ScholarPubMed
Edwards, B K, Brown, M L, Wingo, P A, et al. Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst, 2005; 97: 1407–1427.CrossRefGoogle ScholarPubMed
Alberts, W M. Diagnosis and management of lung cancer executive summary: ACCP Evidence-Based Clinical Practice Guidelines (2nd edition). Chest 2007; 132 (3 Suppl): 1S–19S.CrossRefGoogle Scholar
McCrory, D C, Zelman-Lewis, S, Heitzer, J, et al. Methodology for lung cancer evidence review and guideline development: ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 23S–28S.CrossRefGoogle Scholar
Alberg AJ, Yung RC, Samet J. Epidemiology of lung cancer. In: Murray, J, Nadel, J, Broaddus, C, et al (eds.), Textbook of Respiratory Medicine, 4th edition. Philadelphia, Elsevier, 2004, pp. 1328–1356.Google Scholar
Alberg, A J, Ford, J G, Samet, J M. Epidemiology of lung cancer: ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 29S–55S.CrossRefGoogle Scholar
Haiman, C A, Stram, D O, Wilkens, L R, et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med, 2006; 354: 333–442.CrossRefGoogle ScholarPubMed
Zheng, Y L, Harris, C, Alberg, A, et al. Less efficient G2/M checkpoint is associated with an increased risk of lung cancer in African-Americans. Cancer Research, 2005; 65: 9566–9573.CrossRefGoogle Scholar
Wright, A A, Katz, I T. Tobacco tightrope – balancing disease prevention and economic development in China. N Engl J Med, 2007; 356: 1493–1496.CrossRefGoogle Scholar
Jiang, Y, Ong, M K, Tong, E K, et al. Chinese physicians and their smoking knowledge, attitudes, and practices. Am J Prev Med, 2007; 33: 15–22.CrossRefGoogle ScholarPubMed
Kiryu, T, Hoshi, H, Matsui, E, et al. Endotracheal/endobronchial metastases: Clinicopathologic study with special reference to developmental modes. Chest, 2001; 119: 768–75.CrossRefGoogle ScholarPubMed
Katsimbri, P P, Bamias, A T, Froudrakis, M E, et al. Endobronchial metastases secondary to solid tumors: Report of eight cases and review of the literature. Lung Cancer, 2000; 28: 163–70.CrossRefGoogle ScholarPubMed
Akoglu, S, Ucan, E S, Celik, G, et al. Endobronchial metastases from extrathoracic malignancies. Clin Exp Metastasis, 2005; 22: 587–591.CrossRefGoogle ScholarPubMed
Pastorino, U, Buyse, M, Friedel, G, et al. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg, 1997; 113: 37–49.CrossRefGoogle ScholarPubMed
Hittelman, W N. Genetic instability in epithelial tissues at risk for cancer. Ann N Y Acad Sci. 2001; 952: 1–12.CrossRefGoogle ScholarPubMed
Estellar, M and Herman, J G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol, 2002; 196: 1–7.CrossRefGoogle Scholar
Mountain, C F. A new international staging system for lung cancer. Chest 1986; 89 (4 Suppl): 225S–233S.CrossRefGoogle ScholarPubMed
Goldstraw, P, Crowley, J J, Chansky, K, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (7th) edition of the TNM classification of malignant tumours. J Thorac Oncol, 2007; 2: 706–714.CrossRefGoogle Scholar
Porta, Rami R, Ball, D, Crowley, J, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (7th) edition of the TNM classification for lung cancer. J Thorac Oncol, 2007; 2: 593–602.CrossRefGoogle Scholar
Rusch, V W, Crowley, J, Giroux, D W, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the N descriptors in the forthcoming (7th) edition of the TNM classification for lung cancer. J Thorac Oncol, 2007; 2: 603–612.CrossRefGoogle Scholar
Postmus, P E, Brambilla, E, Chansky, K, et al. The IASLC Lung Cancer Staging Project: Proposals for revision of the M descriptors in the forthcoming (7th) edition of the TNM classification of lung cancer. J Thorac Oncol, 2007; 2: 686–693.CrossRefGoogle Scholar
Mountain, C F and Dresler, C M. Regional lymph node classification for lung cancer staging. Chest 1997; 111: 1718–1723.CrossRefGoogle ScholarPubMed
Naruke, T, Suemasu, K, and Ishikawa, S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg, 1978; 76: 833–39.Google ScholarPubMed
The Japan Lung Cancer Society. Classification of Lung Cancer, 1st English edition. Tokyo: Kanehara & Co.; 2000.
Groome, P A, Bolejack, V, Crowely, J J, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (7th) edition of the TNM classification of malignant tumours. J Thorac Oncol, 2007; 2: 694–705.CrossRefGoogle Scholar
Shepherd, F A, Crowley, J, Houtte, P, et al. The International Association for the Study of Lung Cancer lung cancer staging project: Proposals regarding the clinical staging of small cell lung cancer in the forthcoming (7th) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol, 2007; 2: 1067–1077.CrossRefGoogle Scholar
Silvestri, G A, Gould, M K, Margolis, M L, et al. Noninvasive staging of non-small cell lung cancer: ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest. 2007; 132(3 Suppl): 178S–201S.CrossRefGoogle Scholar
Webb, W, Gatsonis, C, Zerhouni, E, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group. Radiology, 1991; 178: 705–713.CrossRefGoogle Scholar
McLoud, T, Bourgouin, P, Greenberg, R, et al. Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology, 1992; 182: 319–323.CrossRefGoogle ScholarPubMed
Naidich, D P, Sussman, R, Kutcher, W L, et al. Solitary pulmonary nodule: CT-bronchoscopic correlation. Chest, 1988; 93: 595–598.CrossRefGoogle ScholarPubMed
Bilaceroglu, S, Kumcuoglu, Z, Alper, H, et al. CT bronchus sign-guided bronchoscopic multiple diagnostic procedures in carcinomatous solitary pulmonary nodules and masses. Respiration, 1988; 65: 49–55.CrossRefGoogle Scholar
Shitrit, D, Valdsislav, P, Grubstein, A, et al. Accuracy of virtual bronchoscopy for grading tracheobronchial stenosis. Correlation with pulmonary function test and fiberoptic bronchoscopy. Chest, 2005; 128: 3545–3550.CrossRefGoogle ScholarPubMed
Finkelstein, S E, Summers, R M, Nguyen, D M, et al. Virtual bronchoscopy for evaluation of malignant tumors of the thorax. J Thorac Cardiovasc Surg, 2002; 123: 967–972.CrossRefGoogle ScholarPubMed
Kiraly, A P, Helferty, J P, Hoffman, E A, et al. Three-dimensional path planning for virtual bronchoscopy. IEEE Transactions on Medical Imaging, 2004; 23: 1365–1379.CrossRefGoogle ScholarPubMed
Solomon, S B, White, P, Wiener, C M, et al. Three-dimensional CT-guided bronchoscopy with a real-time electromagnetic position sensor: A comparison of two image registration methods. Chest, 2000; 118: 1783–1787.CrossRefGoogle ScholarPubMed
Hautmann, H, Schneider, A, Pinkau, T, et al. Electromagnetic catheter navigation during bronchoscopy. Validation of a novel method by conventional fluoroscopy. Chest, 2005; 128: 382–387.CrossRefGoogle ScholarPubMed
Schwarz, Y, Greif, J, Becker, H D, et al. Real-time electromagnetic navigation bronchoscopy to peripheral lung lesions using overlaid CT images: The first human study. Chest, 2006; 129: 988–994.CrossRefGoogle ScholarPubMed
Gildea, T R, Mazzone, P J, Karnak, D, et al. Electromagnetic navigation diagnostic bronchoscopy: A prospective study. AJRCCM, 2006; 174: 982–989.Google ScholarPubMed
McGuire, F R, Kerley, M, Ochran, T, et al. Radiotherapy monitoring device implantation into peripheral lung cancers: A therapeutic utility of electromagnetic navigational bronchoscopy. J Bronchology, 2007; 14: 173–176.CrossRefGoogle Scholar
McLemore, T L and Bedekar, A R. Accurate diagnosis of peripheral lung lesions (PLL) in a private community hospital employing electromagnetic guidance bronchoscopy (EMB) coupled with a radial endobronchial ultrasound (EBUS). Chest Meeting Abstracts, 2007; 132: 452S.Google Scholar
Krimsky, K, Sethi, S, and Cicernia, J. Tattooing of pulmonary nodules for localization prior to VATS. Chest, 2007; 132: 425S.CrossRefGoogle Scholar
Gupta, N C, Frank, A R, Dewan, N A, et al. Solitary pulmonary nodules: Detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 1992; 184: 441–444.CrossRefGoogle Scholar
Minn, H, Sasadny, K R, Quint, L E, et al. Lung cancer: Reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology, 1995; 196: 167–173.CrossRefGoogle ScholarPubMed
Gould, M K, Fletcher, J, Iannettoni, M D, et al. Evaluation of patients with pulmonary nodules: When is it lung cancer? ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 108S–130S.CrossRefGoogle Scholar
Wahl, R L, Quint, L E, Greenough, R L, et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation. Radiology, 1994; 191: 371–377.CrossRefGoogle ScholarPubMed
Tinteren, H, Hoekstra, O S, Smit, E F,et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The PLUS multicentre randomised trial. Lancet, 2002; 359: 1388–1393.CrossRefGoogle ScholarPubMed
Erasmus, J J, McAdams, H P, Rossi, S E, et al. FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol, 2000; 175: 245–249.CrossRefGoogle ScholarPubMed
Kumar, R, Xiu, Y, Yu, J Q, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004; 45: 2058–2062.Google ScholarPubMed
Rodríguez Fernández, A, Gómez Río, M, Elvira, Llamas J M, et al. Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods in the thoracic and extrathoracic staging of non-small cell lung cancer. Clin Transl Oncol, 2007; 9: 32–39.CrossRefGoogle ScholarPubMed
Giordano, A, Calcagni, M L, Meduri, G, et al. Perfusion lung scintigraphy for the prediction of postlobectomy residual pulmonary function. Chest, 1997; 111: 1542–1547.CrossRefGoogle ScholarPubMed
Colice, G L, Shafazand, S, Griffin, J P, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP Evidenced-based Clinical Practice Guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 161S–177S.CrossRefGoogle Scholar
Brabilla, E, Travis, W D, Colby, T V, et al. The new World Health Organization classification of lung tumours. Eur Respir J, 2001; 18: 1059–1068.CrossRefGoogle Scholar
Yung, R C. Tissue diagnosis of suspected lung cancer: Selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy. Respir Care Clin North Am, 2003 Mar; 9(1): 51–76.CrossRefGoogle Scholar
Rivera, M P and Mehta, A C. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 131S–5148S.CrossRefGoogle Scholar
Barach, A, Bickerman, H, Beck, G, et al: Induced sputum as a diagnostic technique for cancer of the lungs. Arch Intern Med, 1960; 106: 120–126.CrossRefGoogle ScholarPubMed
Scott, W J, Howington, J, Feigenberg, S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 234S–242S.CrossRefGoogle Scholar
Lacasse, Y, Wong, E, Guyatt, G H, et al. Transthoracic needle aspiration biopsy for the diagnosis of localised pulmonary lesions: A meta-analysis. Thorax, 1999; 54: 884–893.CrossRefGoogle Scholar
Schreiber, G and McCrory, D. Performance characteristics of different modalities for diagnosis of suspected lung cancer. Chest, 2003; 123(suppl): 115S–128S.CrossRefGoogle ScholarPubMed
Protopapas, Z and Westcott, J L. Transthoracic needle biopsy of mediastinal lymph nodes for staging lung cancer and other cancers. Radiology, 1996; 199, 489–496.CrossRefGoogle ScholarPubMed
Shinagawa, N, Yamazaki, K, Onodera, Y, et al. CT-guided transbronchial biopsy using an ultrathin bronchoscope with virtual bronchoscopic navigation. Chest, 2004; 125: 1138–1143.CrossRefGoogle ScholarPubMed
Tsushima, K, Sone, S, Hanaoka, T, et al. Comparison of bronchoscopic diagnosis for peripheral pulmonary nodule under fluoroscopic guidance with CT guidance. Respiratory Medicine, 2006; 100: 737–745.CrossRefGoogle ScholarPubMed
Heyer, C M, Kagel, T, Lemburg, S P, et al. Transbronchial biopsy guided by low-dose MDCT: A new approach for assessment of solitary pulmonary nodules. AJR Am J Roentgenol, 2006; 187: 933–939.CrossRefGoogle ScholarPubMed
Asahina, H, Yamazaki, K, Onodera, Y, et al. Transbronchial biopsy using endobronchial ultrasonography with a guide sheath and virtual bronchoscopic navigation. Chest, 2005; 128: 1761–1765.CrossRefGoogle ScholarPubMed
Herth, FJF, Eberhardt, R, Becker, H D, et al. Endobronchial ultrasound-guided transbronchial lung biopsy in fluoroscopically invisible solitary pulmonary nodules. A prospective trial. Chest, 2006; 129: 147–150.Google ScholarPubMed
Kurimoto, N, Murayama, M, Yoshioka, S, et al. Analysis of the internal structure of peripheral pulmonary lesions using endobronchial ultrasonography. Chest, 2002; 122: 1887–1894.CrossRefGoogle ScholarPubMed
Eberhardt, R, Anantham, D, Ernst, A, et al. Multimodality bronchoscopic diagnosis of peripheral lung lesions: A randomized controlled trial. Am J Respir Crit Care Med, 2007; 176: 36–41.CrossRefGoogle ScholarPubMed
Wilson, D S, Bartlett, R J. Improved diagnostic yield of bronchoscopy in a community practice: Combination of electromagnetic navigation system and rapid on-site evaluation. J Bronchol, 2007; 14: 227–232.CrossRefGoogle Scholar
Detterbeck, F C, Jantz, M A, Wallace, M, et al. Invasive mediastinal staging of lung cancer: ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 202S–220S.CrossRefGoogle Scholar
Vallières, E, Pagé, A, and Verdant, A. Ambulatory mediastinoscopy and anterior mediastinotomy. Ann Thorac Surg, 1991; 52: 1122–1126.CrossRefGoogle ScholarPubMed
Wang, K, Brower, R, Haponik, E, et al. Flexible transbronchial needle aspiration for staging of bronchogenic carcinoma. Chest, 1983; 84: 571–576.CrossRefGoogle ScholarPubMed
Bilaçeroglu, S, Cagiotariotaciota, U, Günel, O, et al. Comparison of rigid and flexible transbronchial needle aspiration in the staging of bronchogenic carcinoma. Respiration, 1998; 65: 441–449.CrossRefGoogle ScholarPubMed
Diette, G, White, P, Terry, P, et al. Utility of on-site cytopathology assessment for bronchoscopic evaluation of lung masses and adenopathy. Chest, 2000; 117: 1186–1190.CrossRefGoogle ScholarPubMed
Yasufuku, K, Chiyo, M, Sekine, Y, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest, 2004; 126: 122–128.CrossRefGoogle ScholarPubMed
Herth, FJF, Eberhardt, R, Vilmann, P, et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax, 2006; 61: 795–798.CrossRefGoogle ScholarPubMed
Fritscher-Ravens, A, Bohuslavizki, K H, Brandt, L, et al. Mediastinal lymph node involvement in potentially resectable lung cancer: Comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration. Chest, 2003; 123: 442–451.CrossRefGoogle ScholarPubMed
Annema, J T, Veersteegh, M I, Veselic, M, et al. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA, 2005; 294: 931–936.CrossRefGoogle ScholarPubMed
Robinson, L A, Ruckdeschel, J C, Wagner, H, et al. Treatment of non-small cell lung cancer-stage IIIA: ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 243S–265S.CrossRefGoogle Scholar
Ginsberg, R J and Rubinstein, L. The comparison of limited resection to lobectomy for T1N0 non-small cell lung cancer. LCSG 821. Chest. 1994; 106(Suppl): 318S–319S.Google ScholarPubMed
Martin-Ucar, A E, Nakas, A, Pilling, J E, et al. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg, 2005; 27: 675–679.CrossRefGoogle Scholar
El-Sherif, A, Gooding, W E, Santos, R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: A 13-year analysis. Ann Thorac Surg, 2006; 82: 408–415.CrossRefGoogle Scholar
Zell, J A, Ou, S H, Ziogas, A, et al. Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules. Cancer, 2008; 112: 136–143.CrossRefGoogle ScholarPubMed
Battafarano, R J, Meyers, B F, Guthrie, T J, et al. Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival. Ann Thorac Surg, 2002; 74: 988–993.CrossRefGoogle ScholarPubMed
Prenzel, K L, Mönig, S P, Sinning, J M, et al. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol, 2003; 82: 256–260.CrossRefGoogle ScholarPubMed
Riquet, M, Assouad, J, Bagan, P, et al. Skip mediastinal lymph node metastasis and lung cancer: A particular N2 subgroup with a better prognosis. Ann Thorac Surg, 2005; 79: 225–233.CrossRefGoogle ScholarPubMed
Ilic, N, Petricevic, A, Arar, D, et al. Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer. J Thorac Oncol, 2007; 2: 1018–1021.CrossRefGoogle ScholarPubMed
Pisters, K M and Darling, G. The IASLC Lung Cancer Staging Project: “The nodal zone.” J Thorac Oncol, 2007; 2: 583–584.CrossRefGoogle Scholar
Yildizeli, B, Fadel, E, Mussot, S, et al. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer. Eur J Cardiothorac Surg, 2007; 31: 95–102.CrossRefGoogle ScholarPubMed
Tronc, F, Grégoire, J, Rouleau, J, et al. Long-term results of sleeve lobectomy for lung cancer. Eur J Cardiothorac Surg, 2000 May; 17(5): 550–556.CrossRefGoogle Scholar
Billing, P S, Miller, D L, Allen, M S, et al. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg, 2001; 122: 548–553.CrossRefGoogle ScholarPubMed
Chu, Q, Vincent, M, Logan, D, et al. Taxanes as first-line therapy for advanced non-small cell lung cancer: A systematic review and practice guideline. Lung Cancer, 2005; 50: 355–374.CrossRefGoogle ScholarPubMed
Schiller, J H, Harrington, D, Belani, C P, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346: 92–98.CrossRefGoogle ScholarPubMed
Jett, J R, Schild, S E, Keith, R L, et al. Treatment of non-small cell lung cancer, stage IIIB: ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 266S–276S.CrossRefGoogle Scholar
Socinski, M A, Crowell, R, Hensing, T E, et al. Treatment of non-small cell lung cancer, stage IV: ACCP Evidence-based Clinical Practice Guidelines (2nd edition). Chest, 2007; 132(3 Suppl): 277S–289S.CrossRefGoogle Scholar
Arriagada, R, Bergman, B, Dunant, A, et al. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med, 2004; 350: 351–360.Google Scholar
Douillard, J Y, Rosell, R, Lena, M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol, 2006; 7: 719–727.CrossRefGoogle ScholarPubMed
Winton, T, Livingston, R, Johnson, D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352: 2589–2597.CrossRefGoogle ScholarPubMed
Shepperd, F A, Perira, J R, Ciuleanu, T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med, 2005; 353: 123–132.CrossRefGoogle Scholar
Johnson, D H, Fehrenbacher, L, Novotny, W F, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol, 2004; 22: 2184–2191.CrossRefGoogle ScholarPubMed
Sandler, A, Gray, R, Perry, M C, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med, 2006; 355: 2542–2550.CrossRefGoogle ScholarPubMed
Ou, S H, Zell, J A, Ziogas, A, et al. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: A population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer, 2007; 110: 1532–1541.CrossRefGoogle Scholar
Olaussen, K A, Dunant, A, Fouret, P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med, 2006; 355: 983–991.CrossRefGoogle ScholarPubMed
Ahrendt, S A, Hu, Y, Buta, M, et al. p53 mutations and survival in stage I non-small-cell lung cancer: Results of a prospective study. J Natl Cancer Inst, 2003; 95: 961–970.CrossRefGoogle Scholar
Potti, A, Mukherjee, S, Petersen, R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med, 2006 Aug 10; 355(6): 570–570.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×